Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA
SARS-CoV-2 is liable for the worldwide coronavirus disease (COVID-19) exigency. This
pandemic created the need for all viable treatment strategies available in the market. In this …
pandemic created the need for all viable treatment strategies available in the market. In this …
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
MAA Ibrahim, AHM Abdelrahman… - Journal of biomolecular …, 2021 - Taylor & Francis
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …
Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19
The COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). It is a global health emergency warranting development and implementation …
(SARS-CoV-2). It is a global health emergency warranting development and implementation …
In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
COVID-19, caused by novel coronavirus or SARS-CoV-2, is a viral disease which has
infected millions worldwide. Considering the urgent need of the drug for fighting against this …
infected millions worldwide. Considering the urgent need of the drug for fighting against this …
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease
The COVID-19 pandemic has claimed more than a million lives worldwide within a short
time span. Due to the unavailability of specific antiviral drugs or vaccine, the infections are …
time span. Due to the unavailability of specific antiviral drugs or vaccine, the infections are …
[HTML][HTML] In silico identification and docking-based drug repurposing against the main protease of SARS-CoV-2, causative agent of COVID-19
The rapidly enlarging COVID-19 pandemic caused by novel SARS-coronavirus 2 is a global
public health emergency of unprecedented level. Therefore the need of a drug or vaccine …
public health emergency of unprecedented level. Therefore the need of a drug or vaccine …
Targeting two potential sites of SARS-CoV-2 main protease through computational drug repurposing
Before the rise of SARS-CoV-2, emergence of different coronaviruses such as SARS-CoV
and MERS-CoV has been reported that indicates possibility of the future novel pathogen …
and MERS-CoV has been reported that indicates possibility of the future novel pathogen …
[PDF][PDF] Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach
H Abdel-Halim, M Hajar, L Hasouneh… - Drug Design …, 2022 - Taylor & Francis
Purpose The development of effective treatments for coronavirus infectious disease 19
(COVID-19) caused by SARS-Coronavirus-2 was hindered by the little data available about …
(COVID-19) caused by SARS-Coronavirus-2 was hindered by the little data available about …
Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure …
VN Badavath, A Kumar, PK Samanta… - Journal of …, 2022 - Taylor & Francis
Abstract SARS-COV-2, the novel coronavirus and root of global pandemic COVID-19
caused a severe health threat throughout the world. Lack of specific treatments raised an …
caused a severe health threat throughout the world. Lack of specific treatments raised an …
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a
high transmission rate with currently no drugs or vaccines approved. An alternative powerful …
high transmission rate with currently no drugs or vaccines approved. An alternative powerful …
相关搜索
- sars cov main protease
- sars cov molecular dynamics
- sars cov covid 19
- sars cov drug repurposing
- cov 3cl potent inhibitors
- potent inhibitors main protease
- drug repurposing protease inhibitors
- molecular dynamics protease inhibitors
- covid 19 main protease
- sars cov isatin derivatives
- isatin derivatives main protease
- molecular docking main protease
- approved drugs main protease
- sars cov synthetic flavonoids
- sars cov causative agent
- covid 19 causative agent